2018 Kaiser Permanente National Oncology Conference
 
Symposium Faculty and Planning Committee

FACULTY

Amit Arora, MD
Chief of Oncology & Hematology
The Permanente Medical Group
San Leandro, CA

Corbin Bennett, PharmD
Senior Director of Oncology - National Pharmacy Programs and Services
Kaiser Permanente
Fresno, CA

Farah Brasfield, MD
Hematology and Oncology
Southern California Permanente Medical Group
Anaheim, CA

Gabriel Calzada, MD
Head and Neck Oncology
Southern California Permanente Medical Group
San Marcos, CA

Chun Chao, PhD, MS
Research Scientist II - Department of Research and Evaluation
Southern California Permanente Medical Group
Pasadena, CA

Robert M. Cooper, MD
Physician Director – Cancer Program
Southern California Permanente Medical Group
Los Angeles, CA

Patrick Courneya, MD
Executive Vice President and Chief Medical Officer
Kaiser Foundation Health Plan, Inc. and Hospitals
Oakland, CA

Claudia DeYoung, MD
Internal Medicine
The Permanente Medical Group
Sacramento, CA

Susan Freeman, MD
Oncology
Colorado Permanente Medical Group
Denver, CO

I-Yeh Gong, MD
Hematology and Oncology
The Permanente Medical Group
Sacramento, CA

Reina Haque, PhD, MPH
Research Scientist III – Department of Research & Evaluation
Southern California Permanente Medical Group
Pasadena, CA

Phoebe Harvey, MD
Hematology and Oncology
Northwest Permanente Physicians and Surgeons, PC
Portland, OR

Andrea Harzstark, MD
Urologic Oncologist
The Permanente Medical Group
Oakland, CA 

Mary Ichiuji, MD
Lead Physician Consultant, Beacon Adult Oncology
The Permanente Federation, LLC
Oakland, CA

Daniel Johnson, MD FAAHPM
National Clinical Lead, Palliative Care Medicine
Colorado Permanente Medical Group
Denver, CO

Michael Kanter, MD
Executive VP of Quality and Chief Quality Officer – TPF
Medical Director, Quality and Clinical Analysis – SCPMG
Pasadena, CA

Wui-Leong Koh, MD
Family Medicine
Northwest Permanente Physicians and Surgeons, PC
Portland, OR

Tatjana Kolevska, MD
Oncology
The Permanente Medical Group
Vallejo, CA

Lawrence H. Kushi, ScD
Director of Scientific Policy – Division of Research
Kaiser Permanente Division of Research
Oakland, CA

Yan Li, MD, PhD
Oncology
The Permanente Medical Group
Oakland, CA

Chunnan Liu, MD
Oncology
The Permanente Medical Group
Walnut Creek, CA

Raymond Liu, MD
Hematology and Oncology
The Permanente Medical Group
San Francisco, CA

Crystal Mackall, MD
Associate Director of the Stanford Cancer Institute
Stanford Medicine
Stanford, CA

Leslie Manace, MD MPH
Regional Director, Precision Cancer Tracking
The Permanente Medical Group
Oakland, CA

Eric McGary, MD
Hematology and Oncology
Southern California Permanente Medical Group
Los Angeles, CA

Alexander R. Menter, MD
Oncology
Colorado Permanente Medical Group
Lone Tree, CA 

Brian Missett, MD
Radiation/Oncology
The Permanente Medical Group
Santa Clara, CA

Helen H. Moon, MD
Hematology and Oncology
Southern California Permanente Medical Group
Riverside, CA

Lincoln Nadauld, MD
Executive Director
Intermountain Precision Genomics
St. George, UT

Roberto Rodriguez, MD
Hematology and Oncology
Southern California Permanente Medical Group
Los Angeles, CA

Deborah Schrag, MD, MPH
Professor, Harvard Medical School
Chief, Division of Population Sciences,
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA

Gregory C. Simon, JD
President
Biden Cancer Iniative
Washington, DC

Piyush Srivastava, MD
Oncology
The Permanente Medical Group
Walnut Creek, CA

Jennifer Marie Suga, MD
Oncology
The Permanente Medical Group
Valejo, CA

Devansu Tewari, MD
Gynecologic Oncology
Southern California Permanente Medical Group
Irvine, CA

Eva S. Thomas, MD
Oncology
The Permanente Medical Group
Oakland, CA

Hyma Vempaty, MD
Oncology
The Permanente Medical Group
Santa Clara, CA


FACULTY DISCLOSURE STATEMENT

Kaiser Permanente requires that all planners and faculty participating in CME activities disclose any financial relationship with a commercial interest that might pose a potential, apparent, or real conflict of interest with regard to the individual's contribution to the activity. A commercial interest is defined by the Accreditation Council for Continuing Medical Education (ACCME) as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients; the most common examples are pharmaceutical and medical device companies. All potential conflicts of interest are mitigated prior to the start of the conference and in accordance with the policies of the KP National CME Program.

COMMITTEE

Robert M. Cooper, MD
Symposium Chairman
Physician Director – Cancer Program
Southern California Permanente Medical Group
Los Angeles, CA

Amit Arora, MD
Chief of Oncology & Hematology
The Permanente Medical Group
San Leandro, CA

Reina Haque, PhD, MPH
Research Scientist III – Department of Research & Evaluation
Southern California Permanente Medical Group
Pasadena, CA

Tatjana Kolevska, MD
Oncology
The Permanente Medical Group
Vallejo, CA

Lawrence H. Kushi, ScD
Director of Scientific Policy – Division of Research
Kaiser Permanente Northern California
Oakland, CA

Yan Li, MD, PhD
Oncology
The Permanente Medical Group
Oakland, CA

Helen H. Moon, MD
Hematology and Oncology
Southern California Permanente Medical Group
Riverside, CA

Violeta Rabrenovich, MHA, CHIE
Director – Medical Group Performance Improvement
The Permanente Federation, LLC
Oakland, CA

Eva S. Thomas, MD
Oncology
The Permanente Medical Group
Oakland, CA


NATIONAL CME OFFICE – THE PERMANENTE FEDERATION

Sarah Shimer
Manager, National CME Program
Oakland, CA

SCPMG Physician Education

Carol O’Neal
Sr. Learning Consultant – Regional Physician Education
Southern California Permanente Medical Group
Pasadena, CA

Katherine M. Kleine
Sr. Meeting Planner  – SCPMG Meetings & Events
Southern California Permanente Medical Group
Pasadena, CA